Neon Bloom, Inc.

OTC: NBCO · Healthcare · Biotechnology

PublicHQ New York City, NY · New YorkCIK 0001383637Reports USD

#1 of 1,394 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 37

v0.1 · 5/100 weight · pillars only

↑ Piotroski F, listing tenure · ↓ workforce scale, filing timeliness

Methodology →

Revenue TTM

$3.3M

Rev growth YoY (TTM)

-88.4%

Net income (FY)

—

Employees

Market cap

$1.3M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

No filed financials — private or non-XBRL filer.

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Neon Bloom, Inc. has no structured financials on file — private or non-XBRL filer.

Peers · Healthcare

Restart Life Sciences Corp.——Lakewood-Amedex Biotherapeutics Inc. Common Stock——FOXO Technologies Inc.41D Vicarious Surgical Inc.——

Neighbors

New York →

JPMorgan Chase & Co.$182.4B72B Morgan Stanley$34.3B60C The Goldman Sachs Group, Inc.——Philip Morris International Inc.$40.6B86A American Express Company$41.3B78B+Citigroup Inc.$85.2B56C

Key facts

CEOGreg Bauer

SectorHealthcare

IndustryBiotechnology

HeadquartersNew York City, NY

ExchangeOTC: NBCO

Employees2

IPO date2007-09-21

Latest filings

8-K2019-03-15 8-K2011-09-28 8-K2011-07-28 10-Q2011-05-23 10-K2011-05-16 8-K2011-03-25 8-K2011-03-03 8-K2011-02-08

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.